Aster Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Buy
6,824
+5,774
+550% +$1.35M 0.37% 72
2026
Q1
$174K Buy
+1,050
New +$245K 0.06% 253
2025
Q4
Sell
-22,542
Closed -$4.18M 1265
2025
Q3
$4.18M Buy
22,542
+2,477
+12% +$424K 2.11% 1
2025
Q2
$3.06M Sell
20,065
-3,503
-15% -$538K 0.69% 36
2025
Q1
$3.89M Buy
23,568
+20,188
+597% +$3.16M 0.72% 13
2024
Q4
$489K Sell
3,380
-7,146
-68% -$1.11M 0.19% 149
2024
Q3
$1.71M Buy
+10,526
New +$1.68M 0.37% 65

Other funds holding JNJ

Aster Capital Management's JNJ Position: Q2 2026 in Review

Aster Capital Management increased its Johnson & Johnson (JNJ) stake by 550% in Q2 2026, buying an estimated $1.35M and bringing the position to 6,824 shares worth $1.73M. The position accounts for 0.37% of the portfolio, ranked #72.

Aster Capital Management first reported a position in JNJ in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.18M in Q3 2025. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Aster Capital Management held 6,824 shares of Johnson & Johnson worth $1.73M as of Q2 2026.
  • Aster Capital Management bought 5,774 Johnson & Johnson shares in Q2 2026, an estimated $1.35M.
  • Johnson & Johnson made up 0.37% of Aster Capital Management's portfolio in Q2 2026, its #72 holding.
  • Aster Capital Management first reported a position in Johnson & Johnson in Q3 2024 and has held it in 7 quarters since.
  • Aster Capital Management's Johnson & Johnson position peaked at $4.18M in Q3 2025.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.